Advaxis, Inc.
(NASDAQ : ADXS)

( )
ADXS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.31%186.671.1%$893.59m
GILDGilead Sciences, Inc.
1.90%80.910.9%$837.97m
CELGCelgene Corporation
1.95%95.611.2%$687.44m
BIIBBiogen Inc.
2.80%292.781.2%$564.73m
JUNOJuno Therapeutics, Inc.
0.02%86.5813.5%$436.33m
REGNRegeneron Pharmaceuticals, Inc.
2.55%323.862.7%$403.87m
VRTXVertex Pharmaceuticals Incorporated
5.27%165.901.9%$348.24m
ALXNAlexion Pharmaceuticals, Inc.
3.79%118.932.0%$257.26m
NKTRNektar Therapeutics
1.58%89.606.0%$256.22m
ILMNIllumina, Inc.
3.13%233.843.5%$231.09m
AAgilent Technologies, Inc.
0.03%70.701.5%$186.84m
BLUEBluebird Bio, Inc.
2.41%206.0516.1%$156.27m
INCYIncyte Corporation
3.06%87.802.5%$152.45m
EXASExact Sciences Corporation
-5.82%42.3726.0%$117.22m
BMRNBioMarin Pharmaceutical Inc.
-1.13%83.054.4%$116.68m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.